Jinhe Biotechnology Co Ltd (002688) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.088x

Based on the latest financial reports, Jinhe Biotechnology Co Ltd (002688) has a cash flow conversion efficiency ratio of 0.088x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥229.93 Million ≈ $33.65 Million USD) by net assets (CN¥2.60 Billion ≈ $380.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jinhe Biotechnology Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Jinhe Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Jinhe Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Jinhe Biotechnology Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Jinhe Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jinhe Biotechnology Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shandong Lubei Chemical Co Ltd SHG:600727	0.017x
Newcapec Electronics Co Ltd SHE:300248	0.022x
SimilarWeb Ltd NYSE:SMWB	0.012x
Beijing Bohui Innovation Technology Co Ltd SHE:300318	-0.027x
Mesa Laboratories Inc NASDAQ:MLAB	0.100x
Amotiv Limited TO:AOV	0.090x
Bestore Co Ltd SHG:603719	-0.032x
Shanghai Sinotec Co Ltd SHG:603121	0.048x

Annual Cash Flow Conversion Efficiency for Jinhe Biotechnology Co Ltd (2008–2024)

The table below shows the annual cash flow conversion efficiency of Jinhe Biotechnology Co Ltd from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see Jinhe Biotechnology Co Ltd (002688) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.50 Billion ≈ $365.81 Million	CN¥498.42 Million ≈ $72.94 Million	0.199x	+152.45%
2023-12-31	CN¥2.52 Billion ≈ $368.27 Million	CN¥198.77 Million ≈ $29.09 Million	0.079x	+53.88%
2022-12-31	CN¥2.43 Billion ≈ $354.89 Million	CN¥124.47 Million ≈ $18.21 Million	0.051x	-9.53%
2021-12-31	CN¥2.70 Billion ≈ $394.58 Million	CN¥152.98 Million ≈ $22.39 Million	0.057x	-61.53%
2020-12-31	CN¥1.75 Billion ≈ $256.07 Million	CN¥258.08 Million ≈ $37.77 Million	0.147x	-5.57%
2019-12-31	CN¥1.81 Billion ≈ $264.40 Million	CN¥282.19 Million ≈ $41.29 Million	0.156x	+137.16%
2018-12-31	CN¥1.78 Billion ≈ $260.38 Million	CN¥117.17 Million ≈ $17.15 Million	0.066x	+295.62%
2017-12-31	CN¥1.64 Billion ≈ $239.59 Million	CN¥27.25 Million ≈ $3.99 Million	0.017x	-90.98%
2016-12-31	CN¥1.58 Billion ≈ $231.81 Million	CN¥292.41 Million ≈ $42.79 Million	0.185x	-9.45%
2015-12-31	CN¥1.05 Billion ≈ $154.31 Million	CN¥214.97 Million ≈ $31.46 Million	0.204x	+435.95%
2014-12-31	CN¥956.13 Million ≈ $139.91 Million	CN¥-58.02 Million ≈ $-8.49 Million	-0.061x	-136.82%
2013-12-31	CN¥900.07 Million ≈ $131.71 Million	CN¥148.32 Million ≈ $21.70 Million	0.165x	+60.24%
2012-12-31	CN¥863.55 Million ≈ $126.36 Million	CN¥88.81 Million ≈ $13.00 Million	0.103x	-67.74%
2011-12-31	CN¥334.40 Million ≈ $48.93 Million	CN¥106.59 Million ≈ $15.60 Million	0.319x	-31.19%
2010-12-31	CN¥254.83 Million ≈ $37.29 Million	CN¥118.05 Million ≈ $17.27 Million	0.463x	+291.50%
2009-12-31	CN¥196.03 Million ≈ $28.69 Million	CN¥23.20 Million ≈ $3.39 Million	0.118x	+80.81%
2008-12-31	CN¥177.82 Million ≈ $26.02 Million	CN¥11.64 Million ≈ $1.70 Million	0.065x	--

About Jinhe Biotechnology Co Ltd

SHE:002688 China Drug Manufacturers - Specialty & Generic

Market Cap

$576.99 Million

CN¥3.94 Billion CNY

Market Cap Rank

#11361 Global

#3149 in China

Share Price

CN¥5.11

Change (1 day)

+0.79%

52-Week Range

CN¥4.62 - CN¥7.91

All Time High

CN¥10.94